Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis (MTX01)
This study has been completed.
Sponsor:
MidAmerica Neuroscience Institute
Collaborators:
Consultants in Neurology
Biogen Idec
Information provided by:
MidAmerica Neuroscience Institute
ClinicalTrials.gov Identifier:
NCT00037102
First received: May 15, 2002
Last updated: June 16, 2009
Last verified: November 2003
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | December 2003 |
| Estimated Primary Completion Date: | No date given |